EPO and ovarian carcinoma: Accordingly, human and murine germline‐derived teratocarcinoma cell lines as well as ovarian cancer cell lines respond to EPO by chemotaxis, increased adhesion and phosphorylation of MAPKp42/44 and AKT 44.